News and blogs
377 results found.
Adults in the UK unable to name blood cancer symptom
Over half of the adults in the UK are unable to name a single blood cancer symptom, according to Blood Cancer UK's research.
Yorkshire Farmhouse raises £1.95 million money for vital blood cancer research!
We’ve just found out that the latest Omaze Million Pound House Draw raised a staggering £1.95m in just six weeks to support vital blood cancer research. Yes, you read that right – £1,950,000!
National Cancer Research Institute to close.
Blood Cancer UK's Sarah McDonald said it's sad that this long-standing, multi-partner collaboration is winding down.
Blood Cancer UK renews partnership with RareCan to accelerate research into rare cancers
Renewing the partnership will continue to grow RareCan’s patient community, offering more individuals living with a rare blood cancer diagnosis the opportunity to volunteer to take part in clinical research.
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Remembering Lord Cadogan
We are saddened to learn of the death of our Honorary President, Lord Cadogan KBE DL.
My father would have never believed I'd be running half marathon!
Bradley was a financial advisor at St James’s Place Wealth Management who supported our charity for many years. Bradley lived with MPN (myeloproliferative neoplasms) and was diagnosed with acute myeloid leukaemia in March 2022. Despite beginning chemotherapy immediately, Bradley sadly passed away after just two weeks of treatment. Bradley's daughter, Lara, writes about how she's carrying on her father's fundraising mission.
How thinking differently about Pride is helping us do more to beat blood cancer
How we're supporting the LGBTQ+ community
Targeting tumor stroma could improve immunotherapy response in lymphoma
Blood Cancer UK researchers at King's College London have shown how specific cells known as ‘fibroblast cells’ in lymphoma tumours suppress the body’s immune cells and immunotherapy treatment.
Read Ed's story of being diagnosed with CLL
Ed shares his story of how our Clinical Trials Support Service helped support him through his diagnosis of CLL
My journey on a clinical trial
In this blog, James, who is living with chronic lymphocytic leukaemia, tells us about his journey with blood cancer, and discusses what research means to him.
Blood cancer drug trial results in better outcomes than those on best-available existing medication
A drug, ruxolitinib, has been found to be better at treating the blood cancer - polycythaemia vera (PV) than the best currently available treatment. Researchers looked at how well the drug worked in those who don’t respond well to the first line of treatment in a randomized phase-II clinical trial. Blood Cancer UK funded the work through the Trials Acceleration Programme.
Three years later: should high risk people still be shielding from Covid?
We take a look at what information and data is available regarding the current impact of Covid on people who are high risk, so that those with blood cancer can make informed decisions about how to live their lives socially.
Our letter to the UK Health Security Agency representing immunocompromised people
With a coalition of 11 other charities and organisations representing immunocompromised people, we've written to UK Health Security Agency chief, Dame Jenny Harries, to ask about the pause and review of the ONS Covid-19 Infection Survey and urged her to reconsider. Here is the letter in full:
Research suggests drug improves stem cell transplants for those with multiple myeloma
Researchers in the US have shed light on a way to carry out stem cell transplants in people with multiple myeloma more efficiently, using a drug called motixafortide. The scientific journal, Nature Medicine, published the findings, today (Monday 17 April).
Why taking away that worry of the cancer returning would be life changing…
We’ve recently funded 16 new research projects, but we couldn’t fund research without you, our community who so generously donate to blood cancer research. In this blog we hear from Carole who talks about what this latest research means to her.
We’re delighted to be funding 16 new research projects
We are delighted to announce funding for 16 new research projects across the UK, worth over £4million. The projects span all types of blood cancer and bring our total funding portfolio to 74 different research projects across 23 different institutions in the UK.
I want others to listen and know they're not alone
The new Blood Cancer Heart to Heart podcast is for everyone who has a friend or family member with blood cancer
Findlay runs for Blood Cancer UK
Wil Findlay takes on challenge in memory of Tom Young's wife
Evusheld will not be rolled out on the NHS
The decision has left many disappointed.
